H-CYTE (OTCMKTS:HCYTD) Shares Down 49.5% – What’s Next?

H-CYTE, Inc. (OTCMKTS:HCYTD)’s stock price dropped 49.5% on Friday . The stock traded as low as $2.02 and last traded at $2.02. Approximately 400 shares changed hands during mid-day trading, an increase of 288% from the average daily volume of 103 shares. The stock had previously closed at $4.00.

H-CYTE Stock Performance

The company has a 50 day simple moving average of $2.02 and a 200 day simple moving average of $2.02.

About H-CYTE

H-CYTE, Inc, a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.